Literature DB >> 10374400

N-ras mutations in 43 Chinese cases of acute myeloid leukemia.

W Guo1, B Tang, S Xu, Y Yao, D Ye.   

Abstract

OBJECTIVE: To detect 3 kinds of N-ras mutations in Chinese patients with acute myeloid leukemia (AML).
METHODS: In vitro DNA amplification followed by oligonucleotide dot analysis were used to study N-ras gene mutations in 43 cases of acute myeloid leukemia (AML). 25 healthy people were used as controls. Patients were selected in the Beijing district and consisted of 19 males and 24 females. The average age was 37. The controls were healthy individuals with the average age of 36.5 from the same region. 3 oligonucleotide probes were artificially synthesized to detect mutations in codon 12 and 13 of N-ras.
RESULTS: Five out of 43 AML samples have been found contain G-->A mutation in codon 12.2 have G-->T mutation in codon 12. One has G-->A mutation in codon 13. The mutation rate was 18.6%. None of the controls presented these mutations. The frequency of mutation of N-ras in the AML samples showed statistical differences with that of the controls.
CONCLUSION: Analysis of the results suggests the N-ras mutations may have some relationship with the etiology of acute myeloid leukemia.

Entities:  

Mesh:

Year:  1998        PMID: 10374400

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  2 in total

1.  Frequency of KRAS mutations in adult Korean patients with acute myeloid leukemia.

Authors:  Mi-Jung Park; Soon-Ho Park; Pil-Whan Park; Yiel-Hea Seo; Kyung-Hee Kim; Ji-Hun Jeong; Moon Jin Kim; Jeong-Yeal Ahn; Jae Hoon Lee; Jinny Park; Junshik Hong
Journal:  Int J Hematol       Date:  2013-10-09       Impact factor: 2.490

2.  Determination of Ras-GTP and Ras-GDP in patients with acute myelogenous leukemia (AML), myeloproliferative syndrome (MPS), juvenile myelomonocytic leukemia (JMML), acute lymphocytic leukemia (ALL), and malignant lymphoma: assessment of mutational and indirect activation.

Authors:  D Raepple; F von Lintig; T Zemojtel; M Duchniewicz; A Jung; M Lübbert; G R Boss; J S Scheele
Journal:  Ann Hematol       Date:  2008-09-11       Impact factor: 3.673

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.